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KEY POINTS
• Clinically, bacterial pneumonia is diagnosed much more commonly in
dogs than in cats, though it is likely underrecognized in cats.
• Viral infection followed by bacterial invasion is common in young 
dogs while aspiration pneumonia and foreign body pneumonia appear 
to be more common in older dogs.
• Clinical signs can be acute or chronic and do not always reflect the 
underlying respiratory condition.  
• Definitive diagnosis requires detection of intracellular bacteria in 
airway cytology or clinically significant bacterial growth from an airway
sample, although relevant clinical findings can also support the 
diagnosis.
• Treatment requires identification of underlying and management of 
diseases associated with pneumonia, appropriate antimicrobial 
therapy, and control of airway secretions.  
SYNOPSIS
Bacterial pneumonia is a relatively common clinical diagnosis in dogs 
but seems to occur less often in cats. Underlying etiologies include 
viral infection, aspiration injury, foreign body inhalation and defects in 
clearance of respiratory secretions. Identification of the specific 
organisms involved in disease, appropriate use of antibiotics and 
adjunct therapy, and control of risk factors for pneumonia improve 
management. 
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Introduction
Bacterial pneumonia remains one of the most common clinical 
diagnoses in dogs with acute or chronic respiratory disease. Research 
suggests a complex relationship between viral respiratory diseases, 
environmental factors and development of bacterial and mycoplasmal 
pneumonia in dogs. In cats, bacterial pneumonia is less commonly 
identified than is inflammatory feline bronchial disease, though it 
might be overlooked due to similarities in clinical presentation and 
diagnostic findings. 
Classification of Bacterial Pneumonia
Aspiration
Aspiration pneumonia (AP) results from the inadvertent inhalation of 
gastric acid, oropharyngeal secretions, and/or ingesta and remains a 
common cause of bacterial pneumonia, accounting for roughly 23% of 
clinical diagnoses in a study of human patients admitted to the ICU1. 
Though the true incidence of AP related to all causes is not well 
described in veterinary medicine, the incidence of post-anesthesia or 
sedation AP was reported to be 0.17% in one large multi-institution 
study.2  Other than anesthesia, various conditions predispose to this 
disease. Risk factors that have been identified for the development of 
aspiration pneumonia include esophageal disease, refractory vomiting,
seizures, and laryngeal dysfunction among others3  (Table  1). 
In a healthy animal, physiologic and anatomic features reduce the 
chance of aspiration. During a normal swallow, fluid and food is 
propelled caudally in the oropharynx and through the upper 
esophageal sphincter by contraction of the oral cavity, pharynx and 
tongue. Concurrently, the epiglottis retracts to cover the laryngeal 
aditus and protect the trachea from particulate inhalation. Finally, 
adduction of the arytenoid cartilages contributes to further occlusion of
the upper airways. Any process impeding these primary defenses or 
inhibiting normal swallowing reflexes greatly enhances the likelihood of
aspiration. 
Aspiration injury results from inhalation of either sterile, acidic gastric 
contents (resulting from vomiting or gastric regurgitation) or of septic 
material either from gastric or oral secretions. Irritation induced by 
acid inhalation promotes a local environment where bacterial 
colonization can develop and lead to bacterial pneumonia.4 The 
severity of disease varies depending on the quantity and nature of the 
material aspirated as well as the length of time between the event and
diagnosis. Conscious animals with intact airway reflexes tend to cough 
and prevent massive aspiration injury. Animals under anesthesia or 
with reduced airway reflexes due to neurologic disorders are less likely
to cough in response to the aspiration event and are, therefore, more 
likely to develop diffuse pulmonary infiltrates and serious lung injury. 
In many instances, aspiration injuries occur under general anesthesia 
and it should be noted that the presence of a cuffed endotracheal tube 
does not prevent inadvertent aspiration. Studies have demonstrated 
that concurrent use of cisapride with a proton-pump inhibitor reduces 
the incidence of gastroesophageal reflux under anesthesia5,6 and 
therefore might reduce the likelihood of aspiration pneumonia. 
Canine Infectious Pneumonia
Infectious, or ‘community acquired’ pneumonias in dogs often begin 
with viral colonization and infection of the upper respiratory tract with 
canine respiratory coronavirus, adenovirus, herpesvirus, pneumovirus, 
parainfluenza virus or others7. Often, such diseases are acute and self-
limiting, but in a subset of dogs, inflammation associated with these 
organisms immobilizes the host’s immune defenses and predisposes to
infection with other (often bacterial) respiratory pathogens8. Many 
bacteria have been implicated in canine infectious respiratory disease, 
though special focus has been directed towards Streptococcus 
(specifically equi subsp. zooepidemicus and canis), Mycoplasma cynos,
and Bordetella bronchiseptica.9
Canine infectious respiratory disease (CIRD) is especially prevalent in 
dogs naïve to the pathogens and exposed in over-crowded, stressful 
environments such as animal shelters, boarding kennels, and 
treatment facilities, though it is important to remember that all dogs 
remain susceptible to these pathogens in any environment.  The 
pathophysiology associated with this disease will be discussed later in 
this chapter (Box 1). 
Foreign Body
Inhaled foreign bodies carry mixed bacterial and fungal organisms into 
the lung and are associated with focal or lobar pneumonias that are 
often initially responsive to antimicrobial medications but relapse 
shortly after discontinuation of therapy10,11. Foreign bodies reported in 
the veterinary literature include grass awns, plant or plastic 
materials11. Organisms associated with grass awn inhalation include 
Pasteurella, Streptococcus, Nocardia, Actinomyces and anaerobic 
bacteria, among others.10-12 Most often foreign material remains at the 
carina or enters caudodorsal principle bronchi (accessory, right and left
caudal lobar bronchi). 
Features associated with pulmonary foreign bodies include:
 Young, sporting breeds
 Environmental exposure to grass awns
 Focal, recurrent radiographic alveolar pattern
 History of other cutaneous or visceral foreign bodies
 Spontaneous pneumothorax or pyothorax
Importantly, normal thoracic radiographs do not rule out the possibility
of an airway foreign body and even computed tomography can fail to 
identify an affected bronchus.12  Chronic pulmonary foreign bodies are 
associated with marked inflammation that can lead to massive airway 
remodeling and bronchiectasis, which, when seen on radiographs, 
should raise the degree of suspicion for foreign body.10
Nosocomial
Ventilator-associated pneumonia (VAP) is a common cause of hospital-
acquired pneumonia in people though there are few reports in the 
veterinary literature. Colonization of the oropharynx by pathogenic and
multidrug resistant bacteria occurs and the endotracheal tube acts as 
a conduit to transmit pathogens into the airways, which leads to 
tracheobronchitis and potentially pneumonia. In addition, any animal 
with a compromised respiratory tract or serious systemic disease is 
particularly prone to development of infectious airway disease while 
hospitalized. 
The use of mechanical ventilation in human patients raises the risk of 
nosocomial infection by 6-20 fold.13 No published studies assess the 
risk in ventilated veterinary patients, though a study investigating 
difference in bacterial sensitivity between ventilated and non-
ventilated animals suggested that dogs requiring mechanical 
ventilation were more likely to be infected with bacteria resistant to 
the antimicrobials most commonly used empirically to treat pneumonia
in veterinary practice.14 This parallels the increase in incidence of 
multidrug resistant VAP in human medicine.13 In a recent outbreak of 
Acinetobacter calcoaceticus-Acinetobacter baumannii complex 
infections in a teaching hospital, nine of eleven animals were 
suspected of developing pneumonia due to contaminated equipment 
used during general anesthesia.15 
Immune dysfunction
Both the innate and adaptive immune systems protect against the 
development of infectious airway disease, and a breakdown in either 
increases the likelihood of opportunistic infection. (Table 2) Congenital 
immunodeficiencies have been recognized that make an animal 
particularly sensitive to infectious organisms. Young animals are 
especially prone to the development of bacterial pneumonia due to 
their naïve immune system, and when coupled with alterations to the 
innate immune system such as primary ciliary dyskinesia (PCD), 
complement deficiency or bronchiectasis (congenital or acquired), the 
risk of life-threatening infection increases tremendously. See 
Veterinary Clinics of North America September 2007, Vol 37 (5): pp 
845-860 for a comprehensive review of Respiratory Defenses in Health 
and Disease.   
Any cause of systemic immunocompromise increases the risk for 
bacterial pneumonia, and any additional alterations to the body’s 
natural defense mechanisms dramatically increase the risk. 
Specifically, medications such as chemotherapy, immunosuppressive 
therapy or antitussive therapy increase the likelihood of bacterial 
pneumonia. Underlying respiratory viruses or systemic viruses such as 
FeLV and FIV have the potential to enhance the severity of respiratory 
illness.  
Clinical Signs
Clinical signs of bacterial pneumonia vary depending on its etiology, 
severity and chronicity. They can be acute or peracute in onset or can 
display an insidious onset, resulting in chronic illness, particularly in 
animals with preexisting chronic airway disease. Early in disease, mild 
signs such as an intermittent, soft cough might be the only evidence of
disease. As infection spreads, clinical signs worsen and often include a 
refractory, productive cough, exercise intolerance, anorexia and 
severe lethargy. Owners might note a change in the respiratory 
pattern, with increased panting or rapid breathing and in cases of 
severe infection, cyanosis and orthopnea can be observed.  In general, 
these systemic signs are more often recognized in dogs than in cats.
Cats with pneumonia can display similar clinical signs to dogs, 
although the cough can be misinterpreted as a wretch or vomit by 
owners. Clinical signs and radiographic findings (such as right middle 
lobar consolidation or collapse) can also be considered suggestive of 
inflammatory airway disease rather than pneumonia.16 As disease 
worsens, cats can become tachypneic with short, shallow breaths and 
nasal flaring.17 Rarely do cat owners notice exercise intolerance 
associated with bacterial pneumonia.
Physical Examination
As with the history and clinical signs of bacterial pneumonia, physical 
examination findings vary greatly with the state and severity of 
disease. Dogs or cats with mild disease might have no abnormalities 
detected on physical exam. A change in the respiratory pattern, with 
an increase in rate and effort, can be an early clue to the diagnosis. 
The clinician must pay close attention to thoracic auscultation because
adventitious lung sounds (crackles and wheezes) can be subtle, focal 
or intermittent. In many cases, only harsh or increased lung sounds are
detected rather than crackles.18 Physical examination should assess for
evidence of upper airway signs (e.g. nasal congestion or discharge) 
that can result from lower airway infection, either as an extension of 
epithelial infection or from nasopharyngeal regurgitation of lower 
airway secretions. Thorough auscultation of the trachea and upper 
airway is important for detecting upper airway obstructive disease that
could predispose to pneumonia.
Animals with bacterial pneumonia generally present with mixed 
inspiratory and expiratory signs, similar to those seen with other 
diseases of the pulmonary parenchyma. Fever is detected in 16-50% of
cases, therefore it is not a reliable indicator of disease.8,16,18-20
Diagnosis
Bacterial pneumonia implies sepsis of the lower airway and lungs; 
consequently the diagnosis is confirmed by demonstrating septic 
suppurative inflammation on airway cytology obtained through 
bronchoalveolar lavage (BAL) or tracheal wash, along with a positive 
microbiology culture. In some cases, this is completed easily and yields
results consistent with clinical suspicion. Unfortunately, financial 
limitations or anesthetic concerns sometimes inhibit the ability to 
collect samples needed to confirm a bacterial infection, and in those 
cases a clinical diagnosis of bacterial pneumonia might be presumed 
based on available information.
A clinical diagnosis of bacterial pneumonia should be reached after 
obtaining compelling evidence to suggest a bacterial cause for the 
animal’s clinical signs (after excluding other etiologies), and confirmed 
by resolution of signs following appropriate antimicrobial therapy. 
Acute bacterial pneumonia is a common diagnosis in the small animal 
clinic and can often be easily identified, however early and chronic 
pneumonias are more challenging to recognize because clinical signs 
can be subtle.  
Hematology
The complete blood count is a useful diagnostic test in animals with 
respiratory signs. Bacterial pneumonias are often associated with an 
inflammatory leukogram, characterized primarily by a neutrophilia, 
with or without a left shift and variable evidence of toxic changes 12,21, 
although the absence of inflammatory change does not exclude the 
possibility of pneumonia. 8,18 Furthermore, the leukogram and 
differential can provide clues that suggest bacterial pneumonia is less 
likely. For example, eosinophilia in an animal with respiratory signs 
would be more suggestive of eosinophilic bronchopneumopathy, 
granulomas or parasitic lung diseases as an underlying etiology than a 
bacterial cause. The erythrogram and platelet evaluation are generally 
not helpful in determining a bacterial etiology of respiratory disease.
A biochemistry panel and urinalysis do not always contribute to the 
diagnosis of bacterial pneumonia but can provide clues to the presence
of metabolic or endocrine diseases that could make the development 
of bacterial pneumonia more likely. Similarly, fecal flotation, 
sedimentation, Baermann or heartworm test do not provide evidence 
for bacterial pneumonia but can be helpful in excluding parasitic 
pneumonia in areas where these organisms are endemic.  Cats with 
respiratory conditions should be screened for FeLV and FIV to detect 
systemic causes of immunosuppression.
Pulmonary Function Testing
Arterial blood gas analysis is a useful test to measure the lung’s ability 
to oxygenate.  Ideally, for animals with significant respiratory 
compromise, arterial blood samples should be collected and analyzed 
to determine the severity of pulmonary disease. Furthermore, trends in
arterial oxygen partial pressure can be used to track progression or 
resolution of disease. In many cases, blood gas analysis is not available
or patient factors preclude the acquisition of samples. Pulse oximetry 
is a quick, noninvasive evaluation of oxygen delivery to body tissues 
that measures percentage of hemoglobin saturation with oxygen. It 
provides only a crude assessment of oxygenation and is subject to 
variability, however trends in hemoglobin saturation can provide 
additional clinical support to progression or resolution of disease. 
Additionally, pulse oximetry provides a practical measure of oxygen 
desaturation during anesthesia for airway lavage and should be 
monitored closely during this procedure.  
Thoracic Radiography
Thoracic radiographs are crucial diagnostic tests in the evaluation of 
lower airway and pulmonary parenchymal disease. Radiographic 
evidence of bacterial pneumonia can appear as a focal, multifocal or 
diffuse alveolar pattern, though early in the disease process infiltrates 
can be primarily interstitial.16,22 (Figures 1 and 2) Ventral lung lobes are
most commonly affected in aspiration pneumonia, and a caudodorsal 
pattern would be expected with inhaled foreign bodies or 
hematogenous bacterial spread. A lobar sign is often seen in cases of 
aspiration pneumonia in which the right middle lung lobe is affected. 
(Table 3)
Three view thoracic radiographs (left lateral, right lateral and either 
dorsoventral or ventrodorsal views) should be obtained when 
screening for pneumonia because differential aeration associated with 
positional atelectasis can either mask or highlight pulmonary changes. 
For example, a radiograph taken in left lateral recumbency is preferred
when aspiration is suspected because it will increase aeration of the 
right middle lung lobe, the most commonly affected lobe.
Diffuse radiographic involvement would be expected to suggest more 
severe disease, though radiographic changes lag behind clinical 
disease. Consequently bacterial pneumonia cannot be ruled out in 
animals with acute onset of clinical signs and unremarkable 
radiographs.12 
Advanced Imaging
Advanced imaging is rarely necessary in the diagnosis of 
uncomplicated bacterial pneumonia, though it can be very helpful in 
more complicated cases. Thoracic ultrasound can be used to 
characterize peripheral areas of consolidation and to obtain fine-needle
aspirates for cytology. Cytology is often helpful in distinguishing 
inflammation from neoplastic or fungal disease. Additionally, 
sonographic evaluation can be useful in the detection of superficial 
foxtail foreign bodies when they remain in the periphery of the lobe.12 
(Figures 3 and 4)
Computed tomography (CT) provides greater detail and resolution of 
lesions within the pulmonary parenchyma and gives the clinician better
spatial information regarding the severity and extent of pulmonary 
involvement. In particular, CT is much better at identifying the 
presence and extent of bronchiectasis in comparison to thoracic 
radiography.  In some cases, CT can be useful to identify migration 
tracts associated with inhaled foreign bodies.12 Unfortunately, in most 
cases general anesthesia is required for CT acquisition and prolonged 
recumbency can lead to atelectasis, which is difficult to differentiate 
radiographically from infiltrates.  Repeating the CT in a different 
position after providing several maximal inspirations can alleviate 
atelectasis. Nuclear scintigraphy can be useful for the evaluation of 
ciliary dyskinesia, though secondary causes of mucociliary stasis (i.e. 
infection with Mycoplasma or Bordetella, exposure to smoke) must be 
excluded before assuming the diagnosis of primary ciliary dyskinesia 
(PCD). Due to the time necessary for image acquisition, magnetic 
resonance imaging (MRI) is not commonly used for the diagnosis of 
most respiratory diseases. Positron emission tomography (PET) has not
been evaluated for use in bacterial pneumonia, though it might be 
useful in evaluating patients with atypical infiltrates or mass lesions 
when a definitive diagnosis is not forthcoming.
Bronchoscopic evaluation
Examination of the trachea and bronchial tree should be performed 
systematically. The endoscopist should note the color and character of 
the mucosa and any airway sections, making sure to evaluate all 
branches of the lower airways for evidence of foreign bodies, 
bronchiectasis or collapse (diffuse or focal changes). Airway mucosa in 
a normal animal should be pale pink with visible mucosal and 
pulmonary vessels. Airway bifurcations should appear as narrow, crisp 
mucosal margins.
Animals with pneumonia can have hyperemia of the epithelium, 
prominent mucosal vessels and evidence of airway inflammation, 
appearing as rounded, thickened airway bifurcations and airway 
nodules. Airway secretions are usually opaque, therefore viscous and 
discolored (brown, yellow-green, or red-tinged) secretions can be 
indicative of inflammation or pneumonia. 
Airway sampling
When available, bronchoalveolar lavage (BAL) is preferred for 
collection of a lower airway sample over tracheal wash because the 
trachea and carina are not sterile, even in healthy dogs.23 Additionally, 
the sensitivity for detecting cytologic features of sepsis is greater with 
BAL than tracheal wash.19  However, when only a tracheal wash 
specimen can be obtained, due to the lack of equipment for BAL or 
because of patient instability, collection of a lower airway sample is 
desirable to identify infecting bacteria and to determine appropriate 
antimicrobial therapy through susceptibility testing.  Oropharyngeal 
swabs are not suitable substitutes for making a diagnosis of 
pneumonia.
BAL cell counts in animals with bacterial pneumonia are markedly 
higher than in dogs with chronic bronchitis or other respiratory 
disease.21 Septic, suppurative inflammation is a reliable indicator of 
bacterial pneumonia in dogs21 and is likely indicative of bacterial 
pneumonia in cats. In those cases that lack evidence of airway sepsis 
(intracellular bacteria), BAL cytology generally reveals suppurative or 
mixed inflammation.20 It is important to note that animals with 
Mycoplasma pneumonia can have positive culture in the absence of 
cytologic evidence of sepsis. 
In animals with suspected or confirmed foreign bodies, a BAL sample 
should always be obtained from the affected airway as well as an 
additional site, with both submitted individually for cytologic analysis.  
Airway bacteria are more likely to be seen in the cytologic sample from
the site of the foreign body than from an alternate site.11 Furthermore, 
cytology of BAL samples obtained from multiple lobes can reveal 
different findings, even in cases of sterile inflammatory diseases like 
feline bronchial disease, thus reliance on a single segment BAL 
cytology could lessen the chance of yielding diagnostic results.24
Microbiology
Diagnosis of bacterial pneumonia relies on identification of septic 
inflammation in conjunction with a positive bacterial culture. Typically, 
aerobic and Mycoplasma culture and sensitivity are requested, and in 
cases with markedly purulent secretions or a history of known 
aspiration or foreign bodies, anaerobic cultures should also be 
requested. Samples should be refrigerated in sterile containers until 
submitted. If multiple alveolar segments are sampled during BAL, 
these are usually pooled for culture submission. When anaerobic 
cultures are desired, BAL fluid should be inoculated into the 
appropriate transport media and kept at room temperature until 
submission.
Cultures should be performed whenever possible in order to guide 
appropriate antimicrobial therapy. With overly liberal use of antibiotics,
increasing populations of resistant microbes are being identified – 
particularly in animals with hospital-acquired pneumonia.25,26  However,
airway samples cannot be collected in all animals, and in those 
instances, recommendations regarding antimicrobial stewardship 
should be followed.27
Bacteria commonly isolated from lung washes of cats or dogs with 
bacterial pneumonia include enteric organisms (E. coli, Klebsiella spp.),
Pasteurella spp., coagulase positive Staphylococcus spp., beta-
hemolytic Streptococcus spp., Mycoplasma spp. and Bordetella 
bronchiseptica.20,22  (Table 4)
 
Treatment
Treatment of bacterial pneumonia varies depending on the severity of 
disease, and appropriate antimicrobial therapy is essential. The 
International Society for Companion Animal Infectious Disease (ISCAID)
has published guidelines for treatment of dogs and cats with 
respiratory infections and the these should be consulted for further 
details about recommendations.27  For stable animals with mild 
disease, outpatient therapy consisting of administration of a single, 
oral antibiotic is often all that is necessary. (Table 5) Ideally, 
antimicrobial choices should be based on culture and sensitivity results
from airway lavage samples as resistance to antimicrobials selected 
empirically has been reported in up to 26% of cases.28 For critically ill 
animals in which airways samples cannot be obtained, blood cultures 
might be considered, though there is a lack of data on sensitivity in 
veterinary patients. Regardless, in cases of severe pneumonia, initial 
empiric therapy should be instituted while awaiting culture results. 
Traditionally, antimicrobials have been administered for 3-6 weeks, 
and at least 1-2 weeks beyond the resolution of clinical and/or 
radiographs signs of disease, although there is no evidence to support 
this practice. ISCAID recommendations suggest that shorter duration 
might be appropriate, but there is little data to support this suggestion.
One observational study found similar radiographic and clinical cures in
dogs treated with a short course of antibiotic (less than 14 days) in 
comparison to those that received longer duration of treatment.29 
Regardless of the intended duration of therapy, re-evaluation within 
10-14 days of starting treatment is important to determine response 
and to define optimal length of treatment. 
Animals with more advanced disease require more intensive care, 
including hospitalization with intravenous fluids to maintain hydration. 
Adequate hydration is essential to facilitate clearance of respiratory 
exudates. Nebulization to create liquid particles that enter the lower 
airways (<5 microns in size) can also enhance clearance of secretions. 
Nebulizer types include ultrasonic devices, compressed air nebulizers, 
and a mesh nebulizer. Nebulization with sterile saline can be achieved 
by directing the hosing from the nebulizer into a cage or animal carrier
covered in plastic. Depending on how viscous secretions are, therapy 
can be provided for 15-20 minutes 2-4 times daily. In many cases, 
nebulization coupled with coupage can help the animal expectorate 
airway secretions, although no specific studies in veterinary medicine 
have evaluated this technique. Coupage is performed by cupping the 
hands and gently, rhythmically pounding on both lateral thoracic walls 
in a dorsal to ventral and caudal to cranial direction. Coupage should 
not be performed in animals with regurgitation because any increase in
intrathoracic pressure could exacerbate regurgitation and subsequent 
re-aspiration. 
Supplemental oxygen is necessary for animals with moderate to 
marked hypoxemia (documented by a PaO2 less than 80 mmHg or 
SpO2 less than 94% on room air) in conjunction with increased 
respiratory effort. Oxygen supplementation at 40-60% is provided until 
respiratory difficulty lessens and the animal can be weaned to room 
air. Animals with refractory pneumonia that fail to improve on 
supplemental oxygen can succumb to ventilatory fatigue and need to 
be referred to an intensive care facility for mechanical ventilation.
Clinically, it seems that administration of an oral mucolytic agent such 
as N-acetylcysteine can be useful for animals with retention of thick 
respiratory secretions.  In particular, this can be helpful in dogs with 
moderate to severe bronchiectasis that are prone to chronic or 
recurrent pneumonia. Decreasing the viscosity of airway secretions 
might improve expectoration of fluid and debris that accumulates in 
dependent airways, although no published information is available on 
use of mucolytics in animals. N-acetylcysteine is typically not used via 
nebulization due to risks of bronchoconstriction and epithelial toxicity. 
Under no circumstances is it appropriate to use cough suppressants 
(such as butorphanol or hydrocodone) in the management of bacterial 
pneumonia, particularly when it is complicated by bronchiectasis. By 
decreasing the cough reflex, these drugs perpetuate retention of 
mucus, debris and other material in the airways and therefore hinder 
clearance of infection. Also, furosemide should not be used because 
drying of secretions will trap material in the lower airway and 
perpetuate infection.  
In cases where aspiration pneumonia is suspected, strategies should 
be employed to reduce the chance of re-aspirating through appropriate
treatment of the underlying condition. With disorders of esophageal 
motility, upright feedings of either slurry or meatballs can enhance 
esophageal transit. Furthermore, diets low in fat can increase gastric 
emptying. In patients with refractory vomiting, antiemetic and 
prokinetic agents can be employed to reduce the episodes of vomiting.
Drugs such as maropitant (Cerenia®; 1 mg/kg IV or SQ once daily) or 
ondansetron (Zofran®; 0.3-1 mg/kg IV or SQ once to twice daily) act 
peripherally or centrally to decrease the urge to vomit and are safe to 
use in both cats and dogs. 
The role of antacids in management of aspiration pneumonia remains 
controversial. On one hand, by neutralizing the pH of gastric 
secretions, animals with refractory vomiting or regurgitation are less 
likely to succumb to chemical injury related to aspiration. However, in 
cases treated with acid suppression, the aspirant could be more likely 
to contain a greater concentration of bacteria that can colonize the 
airways and lead to bacterial pneumonia. Though treatment with 
proton pump inhibitors has been shown to reduce the incidence of acid
reflux events in both dogs and cats undergoing anesthesia5,30, no 
controlled studies have assessed the severity of aspiration pneumonia 
or relative risk of using antacid therapy in dogs or cats as a 
preventative measure.  
Because radiographic findings lag behind clinical disease, recheck 
radiographs are not helpful early in the disease process, though they 
are useful to document resolution of disease and should be obtained 
either before or within a week of discontinuation of antimicrobial 
therapy. In cases of refractory pneumonia, recheck radiographs 
midway through therapy can assess resolution or progression of 
disease and will help to guide further diagnostics and therapy.
Serum biomarkers such as acute phase proteins are associated with 
inflammatory disease. Being relatively nonspecific, these biomarkers 
are not clinically useful for diagnosis but might be helpful in 
determining treatment response, facilitating better antimicrobial 
stewardship by suggesting resolution of disease more rapidly than 
thoracic radiographs.31 Further studies are required to establish their 
utility in management of pneumonia.
In animals suspected of having contagious or multidrug resistant 
pathogens, appropriate contact precautions should be employed. 
Isolation gowns, exam gloves and good hand washing technique along 
with appropriate quarantine facilities are essential to prevent 
transmission of disease to other animals or members of the healthcare 
team.
Prognosis
Prognosis for animals with bacterial pneumonia varies depending on 
the severity of disease, the animal’s immunocompetence and the 
virulence of the infectious agent. In general, between 77-94% of 
patients diagnosed with pneumonia are discharged from the 
hospital.8,28,32 No large long-term studies assess the overall prognosis of
animals with MDR bacteria or recurrent pneumonia. Presumably, the 
outcome associated with these cases will be worse. In a recent case 
series of presumed nosocomial multidrug resistant Acinetobacter 
calcoaceticus-Acinetobacter baumannii complex infections, 8/11 
animals with pneumonia died or were euthanized as a consequence of 
their disease.15 
CASE STUDIES
Case Study 1
A 7-year-old MC Bichon Frisé presented for a chronic cough.
History
Six-year history of progressive cough since adoption. The cough is 
described as non-productive, worse in the morning and exacerbated by
aerosols and heavy fragrances. Previous treatment with theophylline 
and doxycycline have not lessened the severity of cough.
Physical examination
Temperature (101.9°F, 38.9°C), pulse (72), and respiratory rate (32) 
were normal.  No heart murmur but soft crackles were ausculted on 
inspiration. A cough was elicited on tracheal palpation.  
Diagnostic evaluation
Chronic cough in a small breed dog is often associated with airway 
collapse or chronic bronchitis, however infectious and neoplastic 
disease must remain on the differential list.  Congestive heart failure is
unlikely in this case given the lack of a heart murmur and normal heart
rate.
A white blood cell count was normal (6650 cells/µl) with 4722 
neutrophils.  Thoracic radiographs revealed dynamic lower airway 
narrowing between lateral projections and a diffuse prominent 
bronchointerstitial pattern, most prominent in the caudal thorax. 
(Figure 5). The larynx appeared to have normal function at anesthetic 
induction. Bronchoscopy revealed mild to moderate dynamic lower 
airway collapse and bronchiectasis of caudodorsal bronchi along with 
airway exudate. Bronchoalveolar lavage samples were hypercellular on
cytology (2500 cells/µl) and revealed septic suppurative inflammation 
(55%, normal 5-8%) with degenerate neutrophils.  Bacterial cultures 
were positive for Pasteurella dagmatis and Fusobacterium sp. In this 
case, chronic inflammatory airway disease likely contributed to the 
dog’s bronchiectasis, which then predisposed to bronchopneumonia.
Case Study 2
A 5-year-old MC DMH was presented for evaluation of acute respiratory
distress.
History
Lethargy and anorexia had been noted 3 days prior to the onset of 
respiratory signs.
Physical examination
Temperature (101.6°F, 38.7°C) and pulse (210) were normal.  
Tachypnea was noted (respiratory rate 60) along with increased 
respiratory effort on inspiration and expiration.  Diffuse expiratory 
wheezes were ausculted.  
Diagnostic evaluation
Acute onset of respiratory difficulty in a cat is most commonly related 
to inflammatory airway disease.  The physical examination is 
consistent with this diagnosis, although it is uncommon for affected 
cats to demonstrate lethargy and anorexia.  Infectious and neoplastic 
diseases were also on the differential diagnosis list, along with 
aspiration and foreign body pneumonia.
Thoracic radiographs demonstrated a focal opacity in the left 
caudal lung lobe and a diffuse bronchial pattern. (Figure 6) Complete 
blood count revealed a normal white blood cell count (8500 cells/µl) 
with a left shift (6800 neutrophils, 1000 bands). Bronchoscopy with 
lavage was performed.  A moderate amount of airway hyperemia and 
edema was noted along with purulent material obstructing several 
airways. Bronchoalveolar lavage cytology had increased cellularity 
(1500 cells/µl, normal 500 cells/µl) with neutrophilic inflammation 
(84%, normal 5-8%).  Neutrophils contained dark blue granular debris, 
suspicious for sepsis.  Aerobic and anaerobic cultures were negative, 
but a pure culture of Mycoplasma was isolated on special media.  A 
diagnosis of Mycoplasma bronchopneumonia was made.  
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Figure legends
Figure 1. Dorsoventral (A) and right lateral (B) thoracic radiographs 
from a dog with an alveolar pattern in the cranioventral lung lobes, 
suggestive of aspiration. Note that in many cases the right middle lung
lobe is most affected, which is best seen on a left lateral orthogonal 
view. 
Figure 2. Dorsoventral (A) and right lateral (B) thoracic radiographs of 
a dog with a focal, patchy interstitial to alveolar pattern in the left 
cranial lung lobe. This dog was diagnosed with a foxtail foreign body, 
which was removed thoracoscopically via lung lobectomy. 
Figure 3. A foxtail foreign body retrieved bronchoscopically from the 
left principle bronchus of a dog with chronic respiratory signs. Foxtails 
are endemic to the Western and Midwestern United States as well as 
some parts of Europe and are associated with mixed aerobic and 
anaerobic infections. Fungal infections seem to occur as a 
consequence of bronchopulmonary foreign bodies less commonly.
Figure 4. CT image of a dog with severe, diffuse pneumonia resulting 
from a chronic foxtail foreign body (see figure 3). The foreign body was
not visible on thoracic radiographs, though is clearly evident in the left 
principle bronchus on this image.
Figure 5. Thoracic radiographs revealing bronchiectasis and a diffuse 
prominent bronchointerstitial pattern, most prominent in the caudal 
thorax (Case study 1).
Figure 6. Thoracic radiographs revealing a focal opacity in the left 
caudal lung lobe and a diffuse bronchial pattern (Case study 2).
Table 1. Factors associated with aspiration pneumonia
 Gastrointestinal disease
o Refractory vomiting 
due to systemic or 
metabolic disease
o Pancreatitis
o Intussusception
o Foreign body 
obstruction
o Ileus
 Anesthesia
o Prolonged anesthesia
o Post procedural 
upper airway obstruction
 Esophageal disease
o Megaesophagus
o Esophageal motility 
disorder
o Hiatal hernia
o Esophageal stricture
o Esophagitis
 Neurologic disease
o Polyneuropathy
o Myasthenia gravis
o Seizure
o Conditions leading to 
prolonged recumbency
 Cricopharyngeal 
dyssynchrony
•      Muscular dystrophy
 Oropharyngeal dysphagia
•       Laryngeal disease
 Tracheostomy
 Breed
o Brachycephalic 
breeds
o Golden Retriever
o Cocker Spaniel
o English Springer 
Spaniel
o Irish Wolfhound
Data from Refs 18,33-35
Table 2. Conditions leading to impaired immune function and 
resulting in increased risk of pneumonia
Congenital Acquired
Innate Primary ciliary dyskinesia
Complement deficiency
Leukocyte adhesion 
deficiency
Bronchiectasis
Secondary ciliary 
dyskinesia
Adaptive Immunoglobulin deficiency
Severe combined 
immunodeficiency
Retrovirus infection 
(e.g. FIV, FeLV)
Endocrine or metabolic
disease (e.g. DM or 
HAC)
Chemotherapy and 
other 
immunosuppressive 
therapy
Splenectomy
Data from Refs36-38.
Table 3. Differential diagnoses for specific radiographic 
patterns 
Lobar alveolar consolidation
Aspiration pneumonia 
(cranioventral, right middle)
Lung lobe torsion (cranial)
Atelectasis secondary to mucus 
plugging (right middle most 
commonly)
Focal alveolar consolidation
Airway foreign body
Granuloma
Primary pulmonary neoplasia 
(caudal lobes)
Metastatic neoplasia
Noncardiogenic pulmonary 
edema
Diffuse alveolar pattern
Acute respiratory distress 
syndrome (ARDS)
Congestive heart failure (perihilar
in dogs)
Fluid overload
Eosinophilic 
bronchopneumopathy
Coagulopathy
Metastatic neoplasia
Fungal pneumonia
Diffuse or focal interstitial 
pattern
Early bacterial pneumonia
Imminent congestive heart failure
Pneumocystis canis infection
Inhalant toxicity (e.g. Paraquat)
Viral pneumonia
Table 4. Bacteria commonly isolated from airway samples of 
canine patients with pneumonia. 
Organism Percentage of isolates
Bordetella bronchiseptica 22-71%
E. coli 11-51%
Klebsiella pneumoniae 2-25%
Pasteurella spp. 3-21%
Mycoplasma spp. 30-70%
Streptococcus spp. 6-21%
Staphylococcus spp. 7-20%
Anaerobes 5-17%
Enterococcus spp. 4-11%
Data from Refs 8,20,28,39 
Table 5. Empiric antibiotic choice for patients with pneumonia
Stable patient, mild clinical signs Monotherapy:
Doxycycline 5 mg/kg PO every 
12 hours
Amoxicillin-clavulanic acid 
13.75mg/kg PO every 12 hours
(dog)
62.5mg PO every 12 hours 
(cat)
Moderate clinical signs Monotherapy: 
As above
Dual therapy:
Amoxicillin 22 mg/kg PO every 
12 hours
Ampicillin 22-30 mg/kg IV 
every 8 hours
Clindamycin 10 mg/kg PO/SQ 
every 12 hours (dog)
10-15 mg/kg PO/SQ every 12 
hours (cat)
AND
Enrofloxacin 10mg/kg PO/IV 
every 24 hours (dog)
5mg/kg PO/IV every 24 hours 
(cat)
Pradofloxacin 7.5 mg/kg PO 
every 24 hours (cat)
Amikacin 15mg/kg SQ every 24
h
Critical patient, severe clinical signs Dual therapy
As above
Monotherapy:
Piperacillin-tazobactam 
50mg/kg IV every 6 hours 
Meropenem 24mg/kg IV every 
24 hours
Imipenem 10mg/kg IV every 8 
hours
Data from Ref 27
BOX 1:  Canine Infectious Respiratory Disease (CIRD) 
Complex – changing the face of Kennel Cough
Canine infectious respiratory disease complex (formerly known as 
“kennel cough”) is a syndrome in which multiple pathogens, both 
viral and bacterial, coinfect either naïve, immunocompromised dogs 
or previously vaccinated dogs. This complex is multifactorial and it 
seems likely that both host and environmental factors play a role in 
the development of illness.40 Organisms associated with this disease 
are ubiquitous, especially in overcrowded housing facilities such as 
animal shelters and training facilities. It is likely that stress induced 
by the new environment and exposure to novel pathogens both play 
a role in development of disease.
In most cases, respiratory signs are present for days to weeks and 
most animals show mild to moderate clinical signs. Typically viral 
infections cause either a bronchopneumonia or bronchointerstitial 
pneumonia due to their propensity to infect and damage type I 
pneumocytes.41 As the condition progresses, desquamation of the 
respiratory epithelium and aggregation of inflammatory cells further 
reduce the lungs’ natural defenses, increasing the potential for 
secondary bacterial colonization and infection.
Previous studies have implicated viral organisms such as canine 
adenovirus or canine parainfluenza42 as major participants in CIRD, 
although recent studies have proposed novel respiratory pathogens 
such as canine respiratory coronavirus7,43-45, canine influenza virus43, 
and canine herpesvirus46 as additional important pathogens 
associated with CIRD. Bordetella bronchiseptica9,47, Streptococcus 
canis, Streptococcus equi subsp. zooepidemicus42, and Mycoplasma 
cynos7,48 have been implicated as secondary bacterial infections 
associated with CIRD. S. equi subsp zooepidemicus infections, in 
particular, have been associated with a rapidly progressive and often
fatal hemorrhagic pneumonia.40,49 Of note, some strains identified in 
outbreaks of this pathogen have been identified as resistant to 
tetracycline antibiotics, often the drug of choice prescribed for other 
bacterial pathogens associated with this complex.
BOX 2:  Feline Lower Respiratory Tract Infections 
Organisms that have been reported as lower respiratory pathogens 
of cats include Pasteurella spp., E. coli, Staphylococcus spp., 
Streptococcus spp., Pseudomonas spp., B. bronchiseptica and 
Mycoplasma spp.50, and specific attention has been paid to 
Mycoplasma spp. due to a possible association with the induction and
exacerbation of asthma in adult and pediatric human patients51. 
However, the association between lower respiratory infection and 
chronic inflammatory lower airway disease in cats is unclear and is a 
topic of ongoing interest.
Mycoplasma species are considered normal flora in the upper 
respiratory tract and their role is controversial in lower respiratory 
tract infection. Because they are rarely identified cytologically and 
specific culture or PCR is needed to document the presence of these 
organisms, the role of Mycoplasma in cats (as well as in dogs) 
remains difficult to define.  
